Genoveffa Franchini

Genoveffa Franchini Genoveffa Franchini is an Italian-American hematologist and retrovirologist. She is a senior investigator in the vaccine branch and head of the animal models and retroviral vaccines section at the National Cancer Institute. Franchini has pioneered research on oncogenes and human retroviruses. She researches HIV vaccine development and translational methods of disease prevention. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Genoveffa Franchini', query time: 0.02s Refine Results
  1. 1
    t-RNA mediates provirus deletion in HIV-infected cells

    t-RNA mediates provirus deletion in HIV-infected cells by Corrado Gurgo, Genoveffa Franchini

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Expression of HIV from a 1-LTR circular DNA in the absence of integration

    Expression of HIV from a 1-LTR circular DNA in the absence of integration by Corrado Gurgo, Claudio Fenizia, Katherine McKinnon, Ru-ching Hsia, Genoveffa Franchini

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.

    Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein. by Michael W Grunst, Ruby A Ladd, Natasha M Clark, Hwi Min Gil, Vadim A Klenchin, Rosemarie Mason, Genoveffa Franchini, Mario Roederer, David T Evans

    Published 2023-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    HTLV-1 p13 Protein Hijacks Macrophage Polarization and Promotes T-Cell Recruitment

    HTLV-1 p13 Protein Hijacks Macrophage Polarization and Promotes T-Cell Recruitment by Ramona Moles, Maria Omsland, Cynthia A. Pise-Masison, Jeffrey J. Subleski, Daniel W. McVicar, Sarkis Sarkis, Anna Gutowska, Luca Schifanella, Melvin Doster, Robyn Washington-Parks, Vincenzo Ciminale, Genoveffa Franchini

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome

    In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome by Hiroki Mizumaki, Shouguo Gao, Zhijie Wu, Fernanda Gutierrez-Rodrigues, Massimiliano Bissa, Xingmin Feng, Emma M. Groarke, Haoran Li, Lemlem Alemu, Diego Quinones Raffo, Ivana Darden, Sachiko Kajigaya, Peter C. Grayson, Genoveffa Franchini, Neal S. Young, Bhavisha A. Patel

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.

    Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques. by Daniel Mendoza, Stephen A Migueles, Julia E Rood, Bennett Peterson, Sarah Johnson, Nicole Doria-Rose, Douglas Schneider, Eva Rakasz, Matthew T Trivett, Charles M Trubey, Vicky Coalter, Claire W Hallahan, David Watkins, Genoveffa Franchini, Jeffrey D Lifson, Mark Connors

    Published 2013-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Co-dependence of HTLV-1 p12 and p8 functions in virus persistence.

    Co-dependence of HTLV-1 p12 and p8 functions in virus persistence. by Cynthia A Pise-Masison, Maria Fernanda de Castro-Amarante, Yoshimi Enose-Akahata, R Cody Buchmann, Claudio Fenizia, Robyn Washington Parks, Dustin Edwards, Martina Fiocchi, Luiz Carlos Alcantara, Izabela Bialuk, Jhanelle Graham, Jean-Claude Walser, Katherine McKinnon, Bernardo Galvão-Castro, Antoine Gessain, David Venzon, Steven Jacobson, Genoveffa Franchini

    Published 2014-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response

    Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response by Mohammad Arif Rahman, Massimiliano Bissa, Hanna Scinto, Savannah E. Howe, Sarkis Sarkis, Zhong-Min Ma, Anna Gutowska, Xunqing Jiang, Christina C. Luo, Luca Schifanella, Ramona Moles, Isabela Silva de Castro, Shraddha Basu, Kombo F. N’guessan, LaTonya D. Williams, Manuel Becerra-Flores, Melvin N. Doster, Tanya Hoang, Hyoyoung Choo-Wosoba, Emmanuel Woode, Yongjun Sui, Georgia D. Tomaras, Dominic Paquin-Proulx, Mangala Rao, James D. Talton, Xiang-Peng Kong, Susan Zolla-Pazner, Timothy Cardozo, Genoveffa Franchini, Jay A. Berzofsky

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: